MGRC

We develop and supply tests used to identify genetic risks associated with diseases (cancer, heart diseases, etc.), health traits (nutrition, fitness, etc.), and adverse reactions to prescription medications. We also provide laboratory services for COVID-19 and other testing... We provide cell engineering and production services for various clinical therapies including Chimeric Antigen Receptor (CAR) T-cell immunotherapy for certain blood and solid cancers. We also produce and supply cells for non-clinical use, e.g., for anti-ageing and wellness markets... Malaysian Genomics Resource Centre Berhad (Bursa Malaysia, ACE, MGRC, 0155) is a leading genomics and biopharmaceutical company based in Southeast Asia. The Group was established in 2004 and listed on the Bursa Malaysia stock exchange in 2010. From pioneering work in genome sequencing, bioinformatics analysis, and genetic screening services, Malaysian Genomics has expanded into the biopharmaceutical sector with the manufacturing of..

Registration numbers: 652790-V (W)